Skip to main content

Cyclospasmol Disease Interactions

There are 3 disease interactions with Cyclospasmol (cyclandelate).

Moderate

Cyclandelate (applies to Cyclospasmol) coronary artery/CV disease

Moderate Potential Hazard, High plausibility. Applicable conditions: Cerebral Vascular Disorder, Ischemic Heart Disease

The use of cyclandelate produces vasodilatory effects which may compromise blood flow to coronary arteries or the cerbrovasculature. Therapy with cyclandelate should be administered cautiously to patients with coronary artery disease or cerebrovascular disease.

Moderate

Cyclandelate (applies to Cyclospasmol) glaucoma

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Glaucoma/Intraocular Hypertension

The use of cyclandelate has been associated with an increase in intraocular pressure. Therapy with cyclandelate should be administered cautiously in patients with glaucoma.

Moderate

Cyclandelate (applies to Cyclospasmol) prolonged bleeding

Moderate Potential Hazard, High plausibility.

The use of high doses of cyclandelate has been associated with prolonged bleeding in animal studies. Therapy with cyclandelate should be administered cautiously in patients with active bleeding or a bleeding tendency.

Switch to professional interaction data

Cyclospasmol drug interactions

There are 93 drug interactions with Cyclospasmol (cyclandelate).


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.